Skip to main content
. Author manuscript; available in PMC: 2016 Jan 12.
Published in final edited form as: Biochem Pharmacol. 2014 Feb 22;89(1):12–19. doi: 10.1016/j.bcp.2014.02.010

Figure 2. Structures of selected heparanase inhibitors.

Figure 2

A. Schematic representation of SST-0001 and chemical modification characterizing the heparin derivative. Given the polymeric nature of SST-0001 (average molecular weight, 20 kDa) a "statistical" representation of the structure is shown.

B. Schematic representation of M402 (average molecular weight, 6 kDa). As for SST-0001, a "statistical" representation of the structure is shown. R=SO3 or Ac.